Ultimovacs ASA

Oslo Stock Exchange ULTI.OL

Ultimovacs ASA Inventory for the year ending December 31, 2024

Ultimovacs ASA Inventory is NA for the year ending December 31, 2024. Inventory is the value of goods held by a company for sale or used in the production process.

Ultimovacs ASA Inventory for the year ending December 31, 2023 was USD 0.00, a -100.00% change year over year.
Ultimovacs ASA Inventory for the year ending December 31, 2022 was USD 297.18 K, a 199.19% change year over year.
Ultimovacs ASA Inventory for the year ending December 31, 2021 was USD 99.33 K, a 0.00% change year over year.
Ultimovacs ASA Inventory for the year ending December 31, 2020 was USD 0.00, a 0.00% change year over year.

Key data

Date	Inventory	Goodwill	Total Assets	Current Liabilities

Oslo Stock Exchange: ULTI.OL

Ultimovacs ASA

CEO	Dr. Carlos de Sousa
IPO Date	June 3, 2019
Location	Norway
Headquarters	Ullernchausséen 64
Employees	17
Sector	Healthcare
Industries Biotechnology Pharmaceuticals Vaccines

Description

Ultimovacs ASA, a pharmaceutical company, develops immunotherapies for cancers. Its lead product candidate is UV1, a peptide-based vaccine that induces T cell response against the universal cancer antigen telomerase. The company was incorporated in 2011 and is headquartered in Oslo, Norway.

Key trends

Past 5 years